| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |